Endotoxin induces late increase in the production of pulmonary proinflarnmatory cytokines in murine lupus-like pristane-primed modelp

被引:2
作者
Chae, BS [1 ]
Park, JS
Shin, TY
机构
[1] Woosuk Univ, Coll Pharm, Wonju 565701, Jeonbuk, South Korea
[2] Nambu Univ, Hlth Coll, Kwangju 506706, South Korea
关键词
TNF-alpha; IL-6; IL-10; IFN-gamma; LPS; lung vascular permeability; pristane; chronic inflammation;
D O I
10.1007/BF02968575
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Lupus-like syndrome is characterized by multiple organ injuries including lungs and kidneys. Endotoxin induces a transiently intent systemic inflammatory response and indirectly transient acute lung injury in normal condition. However, whether endotoxin may trigger the persistent development of lung injury in chronic, inflammatory lupus-like syndrome compared with normal condition remains unclear. We examined the pulmonary vascular permeability and production of proinflammatory cytokines, such as TNF-alpha, IL-6, IL-10 and IFN-y, which play prominent roles in the pathogenesis of lupus-like tissue injury, 6 h and 72 h after i.p. lipopolysaccharide (LPS- endotoxin) injection in pristane-primed chronic inflammation ICR mice characterized by a lupus-like syndrome. These results demonstrated that levels of serum IL-6, IL-10 and IFN-y and bronchoalveolar lavage (BAL) IL-6 and IFN-y were remarkably increased 6 h in LPS-exposed pristane-primed mice compared with pristane-primed controls, while pulmonary vascular permeability and levels of serum and BAL TNF-alpha were not. And levels of BAL TNF-alpha, IL-6 and IL-10 were significantly enhanced 72 h in LPS-exposed pristane-primed mice compared with pristane-primed controls. Also, LPS significantly induced the increased in vitro production of TNF-alpha, IL-6 and IL-10 by lung cells obtained from LPS-exposed pristane-primed mice compared with LPS-exposed normal mice. Our findings indicate that LPS may trigger persistent progression of lung injury through late overproduction of BAL TNF-alpha, IL-6, and IL-10 in lupus-like chronic inflammation syndrome compared with normal condition.
引用
收藏
页码:302 / 309
页数:8
相关论文
共 31 条
[1]  
ANDERSON BO, 1990, J TRAUMA, V30, pS44
[2]   Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice [J].
Balomenos, D ;
Rumold, R ;
Theofilopoulos, AN .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :364-371
[3]   Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles [J].
Barbarin, V ;
Xing, Z ;
Delos, M ;
Lison, D ;
Huaux, F .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2005, 288 (05) :L841-L848
[4]   Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls [J].
Bauer, TT ;
Montón, C ;
Torres, A ;
Cabello, H ;
Fillela, X ;
Maldonado, A ;
Nicolás, JM ;
Zavala, E .
THORAX, 2000, 55 (01) :46-52
[5]  
Childs SG, 2006, ORTHOP NURS, V25, P140
[6]   Infections and autoimmunity - Good or bad? [J].
Christen, U ;
von Herrath, MG .
JOURNAL OF IMMUNOLOGY, 2005, 174 (12) :7481-7486
[7]   Mechanisms of enhanced lung injury during sepsis [J].
Czermak, BJ ;
Breckwoldt, M ;
Ravage, ZB ;
Huber-Lang, M ;
Schmal, H ;
Bless, NM ;
Friedl, HP ;
Ward, PA .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (04) :1057-1065
[8]   Cytokines and systemic lupus erythematosus [J].
Dean, GS ;
Tyrrell-Price, J ;
Crawley, E ;
Isenberg, DA .
ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (04) :243-251
[9]   AIRWAY EPITHELIAL-CELL EXPRESSION OF INTERLEUKIN-6 IN TRANSGENIC MICE - UNCOUPLING OF AIRWAY INFLAMMATION AND BRONCHIAL HYPERREACTIVITY [J].
DICOSMO, BF ;
GEBA, GP ;
PICARELLA, D ;
ELIAS, JA ;
RANKIN, JA ;
STRIPP, BR ;
WHITSETT, JA ;
FLAVELL, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (05) :2028-2035
[10]   Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome [J].
Goodman, RB ;
Strieter, RM ;
Martin, DP ;
Steinberg, KP ;
Milberg, JA ;
Maunder, RJ ;
Kunkel, SL ;
Walz, A ;
Hudson, LD ;
Martin, TR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (03) :602-611